Myocardial infarction as the first symptom of essential thrombocythemia in a young man
Authors:
H. Velanová 1; P. Weber 1; M. Krejčí 2
Authors‘ workplace:
Lékařská fakulta Masarykovy univerzity a Fakultní nemocnice Brno
; Klinika interní, geriatrie a praktického lékařství
Přednosta: prof. MUDr. Hana Matějovská Kubešová, CSc.
1; Interní a hematologická klinika
Přednosta: prof. MUDr. Jiří Mayer, CSc.
2
Published in:
Prakt. Lék. 2014; 94(6): 282-285
Category:
Case Report
Overview
The case study describes a young man diagnosed with acute myocardial infarction, without a history of significant cardiovascular risk factors – apart from smoking. Based on the changes in the blood picture, thrombocytosis was determined as the cause of the myocardial infarction, which was subsequently diagnosed as essential thrombocythemia. Essential thrombocythemia is a rare disease more frequently occurring in the elderly population. An incidence at younger age is rare, but it is vital not to forget about this diagnosis. The aim of this case report is to draw attention to the risk of thrombotic complications in essential thrombocythemia. In order to prevent these often fatal complications, it is important to make an early diagnosis, determine the risk of complications and carry out a follow-up treatment or monitoring of the development of this disease. Generally, the main cause of myocardial infarction is atherosclerosis; however, in younger patients it is also necessary to think of less common risk factors such as essential thrombocythemia.
Keywords:
essential thrombocythemia – myocardial infarction – thrombocytosis – thrombosis
Sources
1. Adam Z, Vorlíček J. Hematologie pro praktické lékaře. Praha: Galén 2007: 121–125.
2. Brière JB. Essential thrombocythemia. Orphanet J Rare Dis 2007; 2: 3. Dostupné též z: http://www.ojrd.com/content/2/1/3.
3. Camachoa FJ, Hernándeza N, Díaza E, et al. Essential thrombocythemia and acute myocardial infarction. Rev Esp Cardiol 2009; 62(5): 583–585.
4. Fischerová B. Specifika akutního infarktu myokardu ve stáří. Interní med 2008; 10(3): 110–112.
5. Greer JP, Foerster J, Rodgers GM, et al. (eds.) Wintrobe’s clinical hematology. 12th ed. Philapdelphia: Lippincott Williams & Wilkins, Wolters Kluwer 2009; 1352–1357.
6. Griesshammer M, Lengfelder E, Döhner K, et al. Essential thrombocythemia – clinical significance, diagnosis and treatment. Dtsch Arztebl 2007; 104(34–35): 2341–2346.
7. Linhart A. Na infarkt u mladých mysleme i jako na symptom. Medical Tribune 2012; 8(5). Dostupné z: http://www.tribune.cz/clanek/26161-na-infarkt-u-mladych-mysleme-i-jako-na-symptom.
8. Penka M, Schwarz J, Pytlík R, a kol. Doporučený postup diagnostiky a terapie esenciální trombocytemie a trombocytemie doprovázející jiné myeloproliferativní choroby. Vnitř. Lék. 2005; 51(6): 741–751.
9. Selingerová M. Vyšetření nezralé destičkové frakce u pacientů s Ph negativním myeloproliferativním onemocněním. Bakalářská práce. Brno: Lékařská fakulta Masarykovy univerzity 2009. Dostupné z: http://is.muni.cz/th/31312/lf_b/.
10. Schwarz J, Penka M. Trombocytózy a trombocytemie. Vnitř. Lék. 2005; 51(7A8): 861–872.
11. Schwarz J, Penka M, Campr V, a kol. Diagnostika a léčba BCR/ABL-negativních myeloproliferativních onemocnění – principy a východiska doporučení CZEMP. Vnitř. Lék. 2011; 57(2): 189–213.
12. Skoda RC. Thrombocytosis. Hematology 2009; 1: 159–167. Dostupné též z: http://asheducationbook.hematologylibrary.org/content/2009/1/159.long.
13. Češka R, a kol. Interna. Praha: Triton 2010: 681–683.
14. Toman O. Akutní infarkt myokardu u mladých pacientů. Dizertační práce. Brno: Lékařská fakulta Masarykovy univerzity 2009. Dostupné z: is.muni.cz/th/18732/lf_d/Disertacni_prace_OT.pdf.
Labels
General practitioner for children and adolescents General practitioner for adultsArticle was published in
General Practitioner
2014 Issue 6
Most read in this issue
- Dysphagia associated with neurological disorders
- Idiopathic orbital pseudotumour
- Patient’s safety at operating theatre in Czech and Swedish hospitals
-
Vaccination and its role in prevention of infectious diseases.
A vaccination refusal – a serious problem of public health